Brief: Marksans Pharma Says Unit Received Marketing Authorisation For Cyanocobalamin Tablets
06/11/2023 06:05
Nov 6 (Reuters) - Marksans Pharma Ltd MARK.NS :
* UNIT RECEIVES MARKETING AUTHORISATION FOR CYANOCOBALAMIN
50MG
FILM COATED TABLETS
* GOT MARKETING AUTHORISATION FROM UK MHRA
Source text for Eikon: ID:nNSEb01S38
Further company coverage: MARK.NS
((reuters.briefs@thomsonreuters.com;))
Recent news on Marksans Pharma
See all newsIndia's Marksans Pharma jumps to over 18-month high after more than doubling quarterly profit
Brief: Marksans Pharma Ltd To Acquire 100% Of Netherlands-Based Qliniq B.V
India's Marksans Pharma jumps to 10-month high after Q4 profit rise
Brief: Marksans Pharma March-Quarter Consol Net Profit 1.48 Billion Rupees
Brief: Marksans Pharma Ltd Receives USFDA Approval For Benzonatate Capsules USP, 100 Mg & 200 Mg